APA (7th ed.) Citation

Walden, L. M., Brandl, E. J., Tiwari, A. K., Cheema, S., Freeman, N., Braganza, N., . . . Müller, D. J. (2019). Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication. Psychiatry research, 279, 111-115. https://doi.org/10.1016/j.psychres.2018.02.055

Chicago Style (17th ed.) Citation

Walden, Lucas M., Eva J. Brandl, Arun K. Tiwari, Sheraz Cheema, Natalie Freeman, Nicole Braganza, James L. Kennedy, and Daniel J. Müller. "Genetic Testing for CYP2D6 and CYP2C19 Suggests Improved Outcome for Antidepressant and Antipsychotic Medication." Psychiatry Research 279 (2019): 111-115. https://doi.org/10.1016/j.psychres.2018.02.055.

MLA (9th ed.) Citation

Walden, Lucas M., et al. "Genetic Testing for CYP2D6 and CYP2C19 Suggests Improved Outcome for Antidepressant and Antipsychotic Medication." Psychiatry Research, vol. 279, 2019, pp. 111-115, https://doi.org/10.1016/j.psychres.2018.02.055.